96 related articles for article (PubMed ID: 1812956)
1. Plasma protein binding of ketoprofen enantiomers in man: method development and its application.
Hayball PJ; Nation RL; Bochner F; Newton JL; Massy-Westropp RA; Hamon DP
Chirality; 1991; 3(6):460-6. PubMed ID: 1812956
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
Dubois N; Lapicque F; Abiteboul M; Netter P
Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
[TBL] [Abstract][Full Text] [Related]
3. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
Jin YX; Tang YH; Zeng S
J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
[TBL] [Abstract][Full Text] [Related]
4. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective serum protein binding of mexiletine enantiomers in man.
McErlane KM; Igwemezie L; Kerr CR
Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):141-4. PubMed ID: 3589151
[TBL] [Abstract][Full Text] [Related]
6. Marked enantioselective protein binding in humans of ketorolac in vitro: elucidation of enantiomer unbound fractions following facile synthesis and direct chiral HPLC resolution of tritium-labelled ketorolac.
Hayball PJ; Holman JW; Nation RL; Massy-Westropp RA; Hamon DP
Chirality; 1994; 6(8):642-8. PubMed ID: 7857775
[TBL] [Abstract][Full Text] [Related]
7. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
Knadler MP; Brater DC; Hall SD
J Pharmacol Exp Ther; 1989 May; 249(2):378-85. PubMed ID: 2724130
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
Sakai T; Maruyama T; Imamura H; Shimada H; Otagiri M
J Pharmacol Exp Ther; 1996 Aug; 278(2):786-92. PubMed ID: 8768732
[TBL] [Abstract][Full Text] [Related]
10. Serum binding of tocainide and its enantiomers in human subjects.
Sedman AJ; Bloedow DC; Gal J
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):165-8. PubMed ID: 6815740
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity.
Hayball PJ; Nation RL; Bochner F
Chirality; 1992; 4(8):484-7. PubMed ID: 1476858
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
Abas A; Meffin PJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
[TBL] [Abstract][Full Text] [Related]
13. [Comparative enantioselectivity of the disposition of two non-steroidal anti-inflammatory agents, ketoprofen and carprofen, in man and animals].
Delatour P; Benoit E; Bourdin M; Gobron M; Moysan F
Bull Acad Natl Med; 1993 Mar; 177(3):515-26; discussion 526-7. PubMed ID: 8364755
[TBL] [Abstract][Full Text] [Related]
14. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.
Hayball PJ; Nation RL; Bochner F; Sansom LN; Ahern MJ; Smith MD
Br J Clin Pharmacol; 1993 Sep; 36(3):185-93. PubMed ID: 9114902
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
Presle N; Lapicque F; Fournel-Gigleux S; Magdalou J; Netter P
Drug Metab Dispos; 1996 Oct; 24(10):1050-7. PubMed ID: 8894504
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein.
Volland C; Sun H; Dammeyer J; Benet LZ
Drug Metab Dispos; 1991; 19(6):1080-6. PubMed ID: 1687014
[TBL] [Abstract][Full Text] [Related]
17. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
Dubois N; Lapicque F; Maurice MH; Pritchard M; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
Drug Metab Dispos; 1993; 21(4):617-23. PubMed ID: 8104120
[TBL] [Abstract][Full Text] [Related]
18. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
19. Effect of ketoprofen and its enantiomers on the renal disposition of methotrexate in the isolated perfused rat kidney.
Karpf DM; Kirkegaard AL; Evans AM; Nation RL; Hayball PJ; Milne RW
J Pharm Pharmacol; 2003 Dec; 55(12):1641-6. PubMed ID: 14738590
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of thiamylal enantiomers in humans.
Sueyasu M; Ikeda T; Taniyama T; Futugami K; Kataoka Y; Oishi R
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):128-32. PubMed ID: 9089003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
